An intermediate-effect size variant in UMOD confers risk for chronic kidney disease. (2022)
Attributed to:
UK Biobank (core renewal)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1073/pnas.2114734119
PubMed Identifier: 35947615
Publication URI: http://europepmc.org/abstract/MED/35947615
Type: Journal Article/Review
Volume: 119
Parent Publication: Proceedings of the National Academy of Sciences of the United States of America
Issue: 33
ISSN: 0027-8424